 | • レポートコード：MRC2304I0186 • 出版社/出版日：Persistence Market Research / 2023年1月19日 • レポート形態：英文、PDF、361ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界の幻覚剤API市場について調査・分析を行い、市場の現状と今後の展望を整理しています。本書は、エグゼクティブサマリー、市場概要、主要市場動向、付加価値のインサイト、市場背景、新型コロナウイルス感染症危機分析、市場規模分析・予測、価格分析、需要分析・予測、製品別（APIグレードシロシビン、APIグレードDMT、LSD API、MDMA API、その他）分析、API化合物別（植物性活性成分、新規合成化合物、代謝産物、アイソトープ標識型標準物質）分析、ソース別（天然、合成、合成生物）分析、グレード別（天然、合成、合成生物）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、Core One Labs Inc.、Cayman Chemical Company (Matreya)、COMPASS Pathways plc、Beckley Psytech、Atai Life Sciences、Tryp Therapeutics、Filament Health、Ceruvia Lifesciences, LLC、BetterLife Pharma、Psygen Pharmaceutical、Mindset Pharmaなどの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・付加価値のインサイト ・市場背景 ・新型コロナウイルス感染症危機分析 ・市場規模分析・予測 ・価格分析 ・需要分析・予測 ・世界の幻覚剤API市場規模：製品別 - APIグレードシロシビンの市場規模 - APIグレードDMTの市場規模 - LSD APIの市場規模 - MDMA APIの市場規模 - その他製品の市場規模 ・世界の幻覚剤API市場規模：API化合物別 - 植物性活性成分における市場規模 - 新規合成化合物における市場規模 - 代謝産物における市場規模 - アイソトープ標識型標準物質における市場規模 ・世界の幻覚剤API市場規模：ソース別 - 天然幻覚剤APIの市場規模 - 合成幻覚剤APIの市場規模 - 合成生物性幻覚剤APIの市場規模 ・世界の幻覚剤API市場規模：グレード別 - 天然幻覚剤APIの市場規模 - 合成幻覚剤APIの市場規模 - 合成生物性幻覚剤APIの市場規模 ・世界の幻覚剤API市場規模：地域別 - 北米の幻覚剤API市場規模 - 中南米の幻覚剤API市場規模 - ヨーロッパの幻覚剤API市場規模 - 東アジアの幻覚剤API市場規模 - 南アジアの幻覚剤API市場規模 - オセアニアの幻覚剤API市場規模 - 中東・アフリカの幻覚剤API市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Psychedelic API Market: Scope of Report
A new publication by Persistence Market Research on the global psychedelic API market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for psychedelic API market products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the psychedelic API market. Shareholders in the psychedelic API market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.
Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the psychedelic API market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the psychedelic API market offers information divided into six important segments – product, API compound, source, grade, application, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
API-Grade Psilocybin
API-Grade DMT
LSD API
MDMA API
Ketamine API
Others
API Compound
Active Plant Components
Novel Synthetic Compounds
Metabolites
Isotopically Labelled Standards
Source
Natural
Synthetic
Bio-Synthetic
Grade
GMP
Non-GMP
Application
Clinical
Research
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for psychedelic APIs over the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the psychedelic API market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the psychedelic API market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the psychedelic API market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Production Strategy
4.2. Volume Consumption
4.3. Production Cost
4.4. Disease Epidemiology
4.5. Regulatory Scenario
4.6. Pipeline Assessment
4.7. Patent Analysis
4.8. PESTEL Analysis
4.9. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Psychedelic Drugs Industry Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Development of Novel Products
5.2.2. Regulatory Imposition
5.2.3. Increasing Spending on Targeted Therapies
5.2.4. Increasing Prevalence Of Depression And Mental Disorders
5.2.5. Strategic Mergers and Acquisitions Among Local
5.2.6. Rising Awareness Towards Mental Health
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.2. 2022 Market Scenario
7. Global Psychedelic API Market Volume (in Kgs) Analysis 2017–2022 and Forecast, 2023–2033
7.1. Historical Market Volume (in Kgs) Analysis, 2017–2022
7.2. Current and Future Market Volume (in Kgs) Projections, 2023–2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Psychedelic API Market- Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Price Break up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.3.1. Pricing Assumptions
9. Global Psychedelic API Market Demand (in Value or Size in US$ Mn) Analysis 2017–2022 and Forecast, 2023–2033
9.1. Historical Market Value (US$ Mn) Analysis, 2017–2022
9.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume (in Kgs) Analysis By Product, 2017–2022
10.3. Current and Future Market Size (US$ Mn) and Volume (in Kgs) Analysis and Forecast By Product, 2023–2033
10.3.1. API-Grade Psilocybin
10.3.2. API-Grade DMT
10.3.3. LSD API
10.3.4. MDMA API
10.3.5. Ketamine API
10.3.6. Others
10.4. Market Attractiveness Analysis By Product
11. Global Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033, By API Compounds
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By API Compounds, 2017–2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By API Compounds, 2023–2033
11.3.1. Active Plant Components
11.3.2. Novel Synthetic Compounds
11.3.3. Metabolites
11.3.4. Isotopically Labeled Standards
11.4. Market Attractiveness Analysis By API Compounds
12. Global Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033, By Source
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis, By Source, 2017–2022
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2023–2033
12.3.1. Natural
12.3.2. Synthetic
12.3.3. Bio-Synthetic
12.4. Market Attractiveness Analysis By Source
13. Global Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033, By Grade
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis, By Grade, 2017–2022
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Grade, 2023–2033
13.3.1. Natural
13.3.2. Synthetic
13.3.3. Bio-Synthetic
13.4. Market Attractiveness Analysis By Grade
14. Global Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033, By Application
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis, By Application, 2017–2022
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2023–2033
14.3.1. Natural
14.3.2. Synthetic
14.3.3. Bio-Synthetic
14.4. Market Attractiveness Analysis By Application
15. Global Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033, By Region
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (in Kgs) Analysis By Region, 2017–2022
15.3. Current and Future Market Value (US$ Mn) and Volume (in Kgs) Analysis and Forecast, 2023–2033
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. East Asia
15.3.5. South Asia
15.3.6. Oceania
15.3.7. Middle East and Africa (MEA)
15.4. Market Attractiveness Analysis By Region
16. North America Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2017–2022
16.3. Current and Future Market Value (US$ Mn) and Volume (in Kgs) Analysis and Forecast, 2023–2033
16.3.1. By Country
16.3.1.1. U.S.
16.3.1.2. Canada
16.3.2. By Product
16.3.3. By API Compounds
16.3.4. By Source
16.3.5. By Grade
16.3.6. By Application
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By API Compounds
16.4.4. By Source
16.4.5. By Grade
16.4.6. By Application
16.5. Market Trends
16.6. Drivers and Restraints – Impact Analysis
16.7. Key Players – Intensity Mapping
16.8. Country Level Analysis & Forecast
16.8.1. U.S. Psychedelic API Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By API Compounds
16.8.1.2.3. By Source
16.8.1.2.4. By Grade
16.8.1.2.5. By Application
16.8.2. Canada Psychedelic API Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By API Compounds
16.8.2.2.3. By Source
16.8.2.2.4. By Grade
16.8.2.2.5. By Application
17. Latin America Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2017–2022
17.3. Current and Future Market Value (US$ Mn) and Volume (in Kgs) Analysis and Forecast, 2023–2033
17.3.1. By Country
17.3.1.1. Mexico
17.3.1.2. Brazil
17.3.1.3. Argentina
17.3.1.4. Rest of Latin America
17.3.2. By Product
17.3.3. By API Compounds
17.3.4. By Source
17.3.5. By Grade
17.3.6. By Application
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By API Compounds
17.4.4. By Source
17.4.5. By Grade
17.4.6. By Application
17.5. Market Trends
17.6. Drivers and Restraints – Impact Analysis
17.7. Key Players – Intensity Mapping
17.8. Country Level Analysis & Forecast
17.8.1. Mexico Psychedelic API Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By API Compounds
17.8.1.2.3. By Source
17.8.1.2.4. By Grade
17.8.1.2.5. By Application
17.8.2. Brazil Psychedelic API Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By API Compounds
17.8.2.2.3. By Grade
17.8.2.2.4. By Application
17.8.2.2.5. By Source
17.8.3. Argentina Psychedelic API Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By API Compounds
17.8.3.2.3. By Source
17.8.3.2.4. By Grade
17.8.3.2.5. By Application
18. Europe Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2017–2022
18.3. Current and Future Market Value (US$ Mn) and Volume (in Kgs) Analysis and Forecast, 2023–2033
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. Italy
18.3.1.3. France
18.3.1.4. U.K.
18.3.1.5. Spain
18.3.1.6. BENELUX
18.3.1.7. Russia
18.3.1.8. Rest of Europe
18.3.2. By Product
18.3.3. By API Compounds
18.3.4. By Source
18.3.5. By Grade
18.3.6. By Application
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By API Compounds
18.4.4. By Source
18.4.5. By Grade
18.4.6. By Application
18.5. Market Trends
18.6. Drivers and Restraints – Impact Analysis
18.7. Key Players – Intensity Mapping
18.8. Country Level Analysis & Forecast
18.8.1. Germany Psychedelic API Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By API Compounds
18.8.1.2.3. By Source
18.8.1.2.4. By Grade
18.8.1.2.5. By Application
18.8.2. Italy Psychedelic API Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By API Compounds
18.8.2.2.3. By Source
18.8.2.2.4. By Grade
18.8.2.2.5. By Application
18.8.3. France Psychedelic API Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By API Compounds
18.8.3.2.3. By Source
18.8.3.2.4. By Grade
18.8.3.2.5. By Application
18.8.4. U.K. Psychedelic API Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By API Compounds
18.8.4.2.3. By Source
18.8.4.2.4. By Grade
18.8.4.2.5. By Application
18.8.5. Spain Psychedelic API Market Analysis
18.8.5.1. Introduction
18.8.5.2. Market Analysis and Forecast by Market Taxonomy
18.8.5.2.1. By Product
18.8.5.2.2. By API Compounds
18.8.5.2.3. By Source
18.8.5.2.4. By Grade
18.8.5.2.5. By Application
18.8.6. BENELUX Psychedelic API Market Analysis
18.8.6.1. Introduction
18.8.6.2. Market Analysis and Forecast by Market Taxonomy
18.8.6.2.1. By Product
18.8.6.2.2. By API Compounds
18.8.6.2.3. By Source
18.8.6.2.4. By Grade
18.8.6.2.5. By Application
18.8.7. Russia Psychedelic API Market Analysis
18.8.7.1. Introduction
18.8.7.2. Market Analysis and Forecast by Market Taxonomy
18.8.7.2.1. By Product
18.8.7.2.2. By API Compounds
18.8.7.2.3. By Source
18.8.7.2.4. By Grade
18.8.7.2.5. By Application
19. East Asia Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2017–2022
19.3. Current and Future Market Value (US$ Mn) and Volume (in Kgs) Analysis and Forecast, 2023–2033
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Product
19.3.3. By API Compounds
19.3.4. By Source
19.3.5. By Grade
19.3.6. By Application
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By API Compounds
19.4.4. By Source
19.4.5. By Grade
19.4.6. By Application
19.5. Market Trends
19.6. Drivers and Restraints – Impact Analysis
19.7. Key Players – Intensity Mapping
19.8. Country Level Analysis & Forecast
19.8.1. China Psychedelic API Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By API Compounds
19.8.1.2.3. By Source
19.8.1.2.4. By Grade
19.8.1.2.5. By Application
19.8.2. Japan Psychedelic API Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By API Compounds
19.8.2.2.3. By Source
19.8.2.2.4. By Grade
19.8.2.2.5. By Application
19.8.3. South Korea Psychedelic API Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By API Compounds
19.8.3.2.3. By Source
19.8.3.2.4. By Grade
19.8.3.2.5. By Application
20. South Asia Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2017–2022
20.3. Current and Future Market Value (US$ Mn) and Volume (in Kgs) Analysis and Forecast, 2023–2033
20.3.1. By Country
20.3.1.1. India
20.3.1.2. Indonesia
20.3.1.3. Malaysia
20.3.1.4. Thailand
20.3.1.5. Rest of South Asia
20.3.2. By Product
20.3.3. By API Compounds
20.3.4. By Source
20.3.5. By Grade
20.3.6. By Application
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By API Compounds
20.4.4. By Source
20.4.5. By Grade
20.4.6. By Application
20.5. Market Trends
20.6. Drivers and Restraints – Impact Analysis
20.7. Key Players – Intensity Mapping
20.8. Country Level Analysis & Forecast
20.8.1. India Psychedelic API Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By API Compounds
20.8.1.2.3. By Source
20.8.1.2.4. By Grade
20.8.1.2.5. By Application
20.8.2. Indonesia Psychedelic API Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By API Compounds
20.8.2.2.3. By Source
20.8.2.2.4. By Grade
20.8.2.2.5. By Application
20.8.3. Malaysia Psychedelic API Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By API Compounds
20.8.3.2.3. By Source
20.8.3.2.4. By Grade
20.8.3.2.5. By Application
20.8.4. Thailand Psychedelic API Market Analysis
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast by Market Taxonomy
20.8.4.2.1. By Product
20.8.4.2.2. By API Compounds
20.8.4.2.3. By Source
20.8.4.2.4. By Grade
20.8.4.2.5. By Application
21. Oceania Psychedelic API Market 2017-2023 and Forecast 2023-2033
21.1. Introduction
21.2. Historical Market Size (US$ Mn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2017–2022
21.3. Current and Future Market Value (US$ Mn) and Volume (in Kgs) Analysis and Forecast, 2023–2033
21.3.1. By Country
21.3.1.1. Australia
21.3.1.2. New Zealand
21.3.2. By Product
21.3.3. By API Compounds
21.3.1. By Source
21.3.2. By Grade
21.3.3. By Application
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By API Compounds
21.4.4. By Source
21.4.5. By Grade
21.4.6. By Application
21.5. Market Trends
21.6. Drivers and Restraints – Impact Analysis
21.7. Key Players – Intensity Mapping
21.8. Country Level Analysis & Forecast
21.8.1. Australia Psychedelic API Market Analysis
21.8.1.1. Introduction
21.8.1.2. Market Analysis and Forecast by Market Taxonomy
21.8.1.2.1. By Product
21.8.1.2.2. By API Compounds
21.8.1.2.3. By Source
21.8.1.2.4. By Grade
21.8.1.2.5. By Application
21.8.2. New Zealand Psychedelic API Market Analysis
21.8.2.1. Introduction
21.8.2.2. Market Analysis and Forecast by Market Taxonomy
21.8.2.2.1. By Product
21.8.2.2.2. By API Compounds
21.8.2.2.3. By Source
21.8.2.2.4. By Grade
21.8.2.2.5. By Application
22. Middle East and Africa (MEA) Psychedelic API Market Analysis 2017–2022 and Forecast 2023–2033
22.1. Introduction
22.2. Historical Market Size (US$ Mn) Trend and Volume (in Kgs) Analysis By Market Taxonomy, 2017–2022
22.3. Current and Future Market Value (US$ Mn) and Volume (in Kgs) Analysis and Forecast, 2023–2033
22.3.1. By Country
22.3.1.1. GCC Countries
22.3.1.2. Turkey
22.3.1.3. North Africa
22.3.1.4. South Africa
22.3.1.5. Rest of Middle East and Africa
22.3.2. By Product
22.3.3. By API Compounds
22.3.4. By Source
22.3.5. By Grade
22.3.6. By Application
22.4. Market Attractiveness Analysis
22.4.1. By Country
22.4.2. By Product
22.4.3. By API Compounds
22.4.4. By Source
22.4.5. By Grade
22.4.6. By Application
22.5. Market Trends
22.6. Drivers and Restraints – Impact Analysis
22.7. Key Players – Intensity Mapping
22.8. Country Level Analysis & Forecast
22.8.1. GCC Countries Psychedelic API Market Analysis
22.8.1.1. Introduction
22.8.1.2. Market Analysis and Forecast by Market Taxonomy
22.8.1.2.1. By Product
22.8.1.2.2. By API Compounds
22.8.1.2.3. By Source
22.8.1.2.4. By Grade
22.8.1.2.5. By Application
22.8.2. Turkey Psychedelic API Market Analysis
22.8.2.1. Introduction
22.8.2.2. Market Analysis and Forecast by Market Taxonomy
22.8.2.2.1. By Product
22.8.2.2.2. By API Compounds
22.8.2.2.3. By Source
22.8.2.2.4. By Grade
22.8.2.2.5. By Application
22.8.3. South Africa Psychedelic API Market Analysis
22.8.3.1. Introduction
22.8.3.2. Market Analysis and Forecast by Market Taxonomy
22.8.3.2.1. By Product
22.8.3.2.2. By API Compounds
22.8.3.2.3. By Source
22.8.3.2.4. By Grade
22.8.3.2.5. By Application
22.8.4. North Africa Psychedelic API Market Analysis
22.8.4.1. Introduction
22.8.4.2. Market Analysis and Forecast by Market Taxonomy
22.8.4.2.1. By Product
22.8.4.2.2. By API Compounds
22.8.4.2.3. By Source
22.8.4.2.4. By Grade
22.8.4.2.5. By Application
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Share Analysis of Top Players
23.3. Market Presence Analysis
24. Competition Analysis
24.1. Competition Dashboard
24.2. Competition Benchmarking
24.3. Competition Deep Dive
24.3.1. Core One Labs Inc.
24.3.1.1. Overview
24.3.1.2. Product Portfolio
24.3.1.3. Sales Footprint
24.3.1.4. Key Financials
24.3.1.5. SWOT Analysis
24.3.1.6. Strategy Overview
24.3.2. Cayman Chemical Company (Matreya)
24.3.2.1. Overview
24.3.2.2. Product Portfolio
24.3.2.3. Sales Footprint
24.3.2.4. Key Financials
24.3.2.5. SWOT Analysis
24.3.2.6. Strategy Overview
24.3.3. COMPASS Pathways plc
24.3.3.1. Overview
24.3.3.2. Product Portfolio
24.3.3.3. Sales Footprint
24.3.3.4. Key Financials
24.3.3.5. SWOT Analysis
24.3.3.6. Strategy Overview
24.3.4. Beckley Psytech
24.3.4.1. Overview
24.3.4.2. Product Portfolio
24.3.4.3. Sales Footprint
24.3.4.4. Key Financials
24.3.4.5. SWOT Analysis
24.3.4.6. Strategy Overview
24.3.5. Atai Life Sciences
24.3.5.1. Overview
24.3.5.2. Product Portfolio
24.3.5.3. Sales Footprint
24.3.5.4. Key Financials
24.3.5.5. SWOT Analysis
24.3.5.6. Strategy Overview
24.3.6. Tryp Therapeutics
24.3.6.1. Overview
24.3.6.2. Product Portfolio
24.3.6.3. Sales Footprint
24.3.6.4. Key Financials
24.3.6.5. SWOT Analysis
24.3.6.6. Strategy Overview
24.3.7. Filament Health
24.3.7.1. Overview
24.3.7.2. Product Portfolio
24.3.7.3. Sales Footprint
24.3.7.4. Key Financials
24.3.7.5. SWOT Analysis
24.3.7.6. Strategy Overview
24.3.8. Ceruvia Lifesciences, LLC
24.3.8.1. Overview
24.3.8.2. Product Portfolio
24.3.8.3. Sales Footprint
24.3.8.4. Key Financials
24.3.8.5. SWOT Analysis
24.3.8.6. Strategy Overview
24.3.9. BetterLife Pharma
24.3.9.1. Overview
24.3.9.2. Product Portfolio
24.3.9.3. Sales Footprint
24.3.9.4. Key Financials
24.3.9.5. SWOT Analysis
24.3.9.6. Strategy Overview
24.3.10. Psygen Pharmaceutical
24.3.10.1. Overview
24.3.10.2. Product Portfolio
24.3.10.3. Sales Footprint
24.3.10.4. Key Financials
24.3.10.5. SWOT Analysis
24.3.10.6. Strategy Overview
24.3.11. Mindset Pharma
24.3.11.1. Overview
24.3.11.2. Product Portfolio
24.3.11.3. Sales Footprint
24.3.11.4. Key Financials
24.3.11.5. SWOT Analysis
24.3.11.6. Strategy Overview
25. Assumptions and Acronyms Used
26. Research Methodology
